CFD'er er komplekse instrumenter, og der er stor risiko for at miste penge hurtigt på grund af gearing. 84% af individuelle investorer taber penge, når de handler CFD'er med denne udbyder. Du bør overveje, om du forstår, hvordan CFD'er virker, og om du har råd til at løbe en høj risiko for at miste dine penge.
US Dansk
Land • United States
    Enhed • The products and services listed on this website are not available to US residents.
    English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文

    Handel Avalon GloboCare Corp. - AVCO CFD

    -
    0%
    • Opsummering
    • Historisk Data
    • Begivenheder
    • Resultatopgørelse
    • Saldo
    • Cash flow
    • Ejerskab
    Handelsbetingelser
    Spænd -
    Long position, gebyr natten over

    Long position overnight fee

    Margin. Your investment $1,000.00
    Gebyr for natten over -0.025457 %
    Charges from borrowed part ($-1.02)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    Gå til platform
    		-0.025457%
    Short position, gebyr natten over

    Short position overnight fee

    Margin. Your investment $1,000.00
    Gebyr for natten over 0.003235 %
    Charges from borrowed part ($0.13)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    Gå til platform
    		0.003235%
    Gebyr natten over, tid 21:00 (UTC)
    Min. handlet mængde 1
    Valuta USD
    Margen 20%
    Aktiebørs United States of America
    Kommission på handel 0%

    *Information provided by Capital.com

    Nøglestatistikker
    Tidligere luk* N/A
    Åben* N/A
    1-Års Ændring* N/A
    Dagens Spænd* N/A
    52-Ugers Spænd 0.37-1.07
    Gennemsnitlig Volumen (10 dage) 214.29K
    Gennemsnitlig Volumen (3 måneder) 4.05M
    Market Cap 37.89M
    P/E-forhold -100.00K
    Udestående aktier 99.98M
    Omsætning 1.24M
    EPS -0.13
    Dividend (Udbytte %) N/A
    Beta 0.81
    Næste indtjeningsopgørelse Mar 28, 2023

    Al data kommer fra Refinitiv, med undtagelse af data markeret med en asterisk, som er *data fra Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Luk Change Change (%) Åben High Low

    Avalon GloboCare Corp. Events

    Tid (UTC) (UTC) Land Begivenhed
    No events scheduled
    Se alle begivenheder
    • Årlig
    • Pr kvartal
    2021 2020 2019 2018 2017
    Total omsætning 1.39097 1.37776 1.54631 1.56229 1.07755
    Omsætning 1.39097 1.37776 1.54631 1.56229 1.07755
    Kost af omsætning, Total 0.97645 0.98756 1.20639 1.17427 0.82979
    Bruttofortjeneste 0.41452 0.3902 0.33992 0.38802 0.24776
    Totale Driftsudgifter 10.2248 13.8318 20.9235 9.19342 4.95541
    Salgs/Generelle/Admin. Udgifter, Total 6.82843 11.8901 16.8943 8.00077 2.79535
    Depreciation / Amortization 0.14124 0.14233 0.05819 0.01838 0.00894
    Driftsindtægter -8.83383 -12.454 -19.3772 -7.63113 -3.87786
    Renteindkomst (Udgift), Netto Ikke-Drift -0.26094 -0.22043 2.16601 -0.47023 -0.19398
    Netto Indkomst Før Skat -9.0905 -12.6794 -18.0702 -8.0523 -4.04965
    Netto Indkomst Efter Skat -9.0905 -12.6794 -18.0702 -8.0523 -4.04965
    Netto Indkomst Før Ekstra Ting -9.0905 -12.6794 -18.0702 -7.77412 -3.46429
    Netto Indkomst -9.0905 -12.6794 -18.0702 -7.77412 -3.46429
    Indkomst Tilgængelig for Almindelige Uden Ekstra Ting -9.0905 -12.6794 -18.0702 -7.77412 -3.46429
    Indkomst Tilgængelig for Almindelige Uden Ekstra Ting -9.0905 -12.6794 -18.0702 -7.77412 -3.46429
    Fortyndet Netto Indkomst -9.0905 -12.6794 -18.0702 -7.77412 -3.46429
    Fortyndet Vægtet Gennemsnit Aktier 84.911 79.5081 75.1169 72.0041 65.0335
    Fortyndet EPS Uden Ekstraordinære Ting -0.10706 -0.15947 -0.24056 -0.10797 -0.05327
    Dividends per Share - Common Stock Primary Issue 0 0
    Fortyndet Normaliseret EPS -0.09087 -0.15947 -0.22711 -0.10797 -0.03295
    Usædvanlig Udgift (Indkomst) 1.375 0 1.01001 0 1.32134
    Andre, Netto 0.00427 -0.00498 -0.85894 0.04908 0.0222
    Minoritetsrente 0 0 0 0.27817 0.58536
    Forskning & Udvikling 0.90369 0.81177 1.75462
    Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
    Total omsætning 0.29763 0.3342 0.48676 0.28023 0.28977
    Omsætning 0.29763 0.3342 0.48676 0.28023 0.28977
    Kost af omsætning, Total 0.21845 0.23635 0.31806 0.20515 0.21689
    Bruttofortjeneste 0.07918 0.09785 0.1687 0.07508 0.07288
    Totale Driftsudgifter 2.42457 2.59719 2.45174 2.58251 2.59336
    Salgs/Generelle/Admin. Udgifter, Total 2.08944 2.01189 1.9096 2.13857 2.16328
    Forskning & Udvikling 0.11668 0.34896 0.22407 0.23879 0.21319
    Driftsindtægter -2.12694 -2.26299 -1.96498 -2.30228 -2.30359
    Renteindkomst (Udgift), Netto Ikke-Drift -0.05261 -0.07128 -0.06445 -0.06155 -0.06366
    Andre, Netto 0.10901 0.00002 0.0052 -0.00108 0.00013
    Netto Indkomst Før Skat -2.07054 -2.33425 -2.02422 -2.36491 -2.36712
    Netto Indkomst Efter Skat -2.07054 -2.33425 -2.02422 -2.36491 -2.36712
    Minoritetsrente 0 0 0 0 0
    Netto Indkomst Før Ekstra Ting -2.07054 -2.33425 -2.02422 -2.36491 -2.36712
    Netto Indkomst -2.07054 -2.33425 -2.02422 -2.36491 -2.36712
    Indkomst Tilgængelig for Almindelige Uden Ekstra Ting -2.07054 -2.33425 -2.02422 -2.36491 -2.36712
    Indkomst Tilgængelig for Almindelige Uden Ekstra Ting -2.07054 -2.33425 -2.02422 -2.36491 -2.36712
    Fortyndet Netto Indkomst -2.07054 -2.33425 -2.02422 -2.36491 -2.36712
    Fortyndet Vægtet Gennemsnit Aktier 88.5024 86.2234 85.3624 84.6237 83.4131
    Fortyndet EPS Uden Ekstraordinære Ting -0.0234 -0.02707 -0.02371 -0.02795 -0.02838
    Dividends per Share - Common Stock Primary Issue 0 0 0 0
    Fortyndet Normaliseret EPS -0.0234 -0.02707 -0.02371 -0.02795 -0.02838
    • Årlig
    • Pr kvartal
    2021 2020 2019 2018 2017
    Totale Nuværende Aktiver 1.32304 1.28634 1.5711 3.62543 3.23498
    Likvider og Kortsigtede Investeringer 0.80754 0.72658 0.76489 2.25229 3.02703
    Cash 0.80754 0.72658 0.76489 2.25229 3.02703
    Totale Tilgodehavender, Netto 0.09087 0.0354 0.24389 0.05222 0.04865
    Accounts Receivable - Trade, Net 0.03362 0.0354 0.24389 0.05222 0.04865
    Prepaid Expenses 0.23627 0.24462 0.47931 1.08438 0.11417
    Other Current Assets, Total 0.18837 0.27974 0.08301 0.22355 0.04246
    Total Assets 10.2422 10.3663 10.4905 13.3957 12.669
    Property/Plant/Equipment, Total - Net 8.03562 8.30213 8.33711 8.12944 7.67179
    Property/Plant/Equipment, Total - Gross 8.99685 9.15433 8.86106 8.4185 7.76825
    Accumulated Depreciation, Total -0.96123 -0.8522 -0.52396 -0.28906 -0.09646
    Total Current Liabilities 4.40166 2.59239 2.83546 1.14172 5.36018
    Payable/Accrued 1.67186 1.07927 1.14095 0.04509 0.03993
    Accrued Expenses 2.33979 1.44349 1.61627 0.81339 0.22102
    Notes Payable/Short Term Debt 0 0 0 0 1.5
    Other Current Liabilities, Total 0.06963 0.07824 0.27655 3.59921
    Total Liabilities 7.15782 6.24935 6.02546 1.27952 4.77479
    Total Long Term Debt 2.75026 3.59 3.19 1 0
    Total Equity 3.0844 4.11692 4.46507 12.1162 7.89424
    Preferred Stock - Non Redeemable, Net 0 0 0 0 0
    Common Stock 0.0089 0.00828 0.00767 0.00738 0.00703
    Additional Paid-In Capital 54.8886 46.8564 34.593 24.1534 11.4903
    Retained Earnings (Accumulated Deficit) -51.1253 -42.0348 -29.3554 -11.2852 -3.51108
    Other Equity, Total -0.16527 -0.19051 -0.25775 -0.23686 -0.09199
    Total Liabilities & Shareholders’ Equity 10.2422 10.3663 10.4905 13.3957 12.669
    Total Common Shares Outstanding 88.4552 82.2753 76.2108 73.3108 70.2786
    Total Inventory 0.01299 0.00267
    Goodwill, Net 0 -0.92377
    Intangibles, Net 0 1.25569 2.50703
    Other Long Term Assets, Total 0.20471 0.1442 0 0.17901
    Accounts Payable 0.0067 0.00003
    Minority Interest 0 0 0 -0.8622 -0.58539
    Long Term Investments 0.51563 0.52176 0.4831 0.38516
    Long Term Debt 2.75026 3.59 3.19 1
    Treasury Stock - Common -0.5225 -0.5225 -0.5225 -0.5225
    Note Receivable - Long Term 0.16321 0.11184 0.09924
    Other Liabilities, Total 0.0059 0.06695
    Current Port. of LT Debt/Capital Leases 0.39
    Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
    Totale Nuværende Aktiver 0.91352 1.32304 1.25793 1.32533 2.16418
    Likvider og Kortsigtede Investeringer 0.52629 0.80754 0.53225 0.6853 1.69254
    Cash 0.52629 0.80754 0.53225 0.6853 1.69254
    Totale Tilgodehavender, Netto 0.11071 0.09087 0.09331 0.05533 0.06541
    Accounts Receivable - Trade, Net 0.04407 0.03362 0.04707 0.02365 0.02347
    Prepaid Expenses 0.07461 0.23627 0.38841 0.35031 0.20912
    Other Current Assets, Total 0.20191 0.18837 0.24396 0.23439 0.19711
    Total Assets 9.66868 10.2422 10.3938 10.3778 11.2852
    Property/Plant/Equipment, Total - Net 7.91903 8.03562 8.14861 8.26656 8.32664
    Long Term Investments 0.50399 0.51563 0.52057 0.53395 0.5322
    Note Receivable - Long Term 0.15527 0.16321 0.15748 0.10656 0.10917
    Other Long Term Assets, Total 0.17687 0.20471 0.30917 0.14546 0.15302
    Total Current Liabilities 5.14789 4.40166 4.53588 3.68013 3.22379
    Payable/Accrued 1.97682 1.67186 1.48934 1.27775 1.09006
    Accrued Expenses 3.17107 2.33979 2.65654 2.01238 1.74373
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases 0 0.39 0.39 0.39 0.39
    Total Liabilities 8.38815 7.15782 8.54012 7.14912 6.63837
    Total Long Term Debt 3.24026 2.75026 3.96319 3.39319 3.30525
    Long Term Debt 3.24026 2.75026 3.96319 3.39319 3.30525
    Minority Interest 0 0 0 0 0
    Other Liabilities, Total 0 0.0059 0.04106 0.0758 0.10934
    Total Equity 1.28053 3.0844 1.85363 3.22873 4.64684
    Preferred Stock - Non Redeemable, Net 0 0 0 0 0
    Common Stock 0.00892 0.0089 0.00861 0.00856 0.00849
    Additional Paid-In Capital 55.1532 54.8886 51.3357 50.6879 49.756
    Retained Earnings (Accumulated Deficit) -53.1958 -51.1253 -48.791 -46.7668 -44.4019
    Treasury Stock - Common -0.5225 -0.5225 -0.5225 -0.5225 -0.5225
    Other Equity, Total -0.16325 -0.16527 -0.17716 -0.17845 -0.19323
    Total Liabilities & Shareholders’ Equity 9.66868 10.2422 10.3938 10.3778 11.2852
    Total Common Shares Outstanding 88.6258 88.4552 85.5324 85.0809 84.4236
    Property/Plant/Equipment, Total - Gross 8.99685
    Accumulated Depreciation, Total -0.96123
    • Årlig
    • Pr kvartal
    2021 2020 2019 2018 2017
    Netto indkomst/Startlinje -9.0905 -12.6794 -18.0702 -8.0523 -4.04965
    Likvider Fra Driftsaktiviteter -5.02448 -7.5461 -7.07987 -4.39602 -1.33969
    Likvider Fra Driftsaktiviteter 0.31176 0.31478 0.50674 0.52284 0.18164
    Ikke-Likvide Ting 2.2545 5.67477 8.84566 3.14595 2.28408
    Cash Taxes Paid 0 0 0.02156
    Likvid Rente Betalt 0 0.05 0.10906 0.37742 0
    Ændringer i Driftskapital 1.49976 -0.85621 1.63789 -0.01251 0.24424
    Likvider fra Investeringsaktiviteter -0.06814 -0.16919 -0.55297 -1.30781 -8.01445
    Kapitaludgifter -0.02783 -0.11121 -0.39378 -0.85465 -8.08648
    Andre Investerings-Cash-Flow-Ting, Total -0.0403 -0.05797 -0.15919 -0.45316 0.07203
    Likvider fra Financieringsaktiviteter 5.17013 7.66428 6.15491 5.04222 9.50223
    Financiering af Cash-Flow-Ting -0.24043 -0.53982 -0.90883 -0.4863 -0.14778
    Udstedelse (Pensionering) af Aktier, Netto 2.8603 7.8041 6.27374 6.02851 8.15
    Udenlandsk Børs Effekter 0.00344 0.01269 -0.00947 -0.11313 -0.00724
    Netto Ændring i Likviditet 0.08096 -0.03831 -1.4874 -0.77475 0.14084
    Udstedelse (Pensionering) af Gæld, Netto 2.55026 0.4 0.79 -0.5 1.5
    Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
    Net income/Starting Line -2.07054 -9.0905 -6.75625 -4.73203 -2.36712
    Cash From Operating Activities -0.51121 -5.02448 -3.30752 -2.59355 -1.51553
    Cash From Operating Activities 0.08498 0.31176 0.22674 0.14129 0.07888
    Non-Cash Items 0.65725 2.2545 1.71006 1.18567 0.62097
    Changes in Working Capital 0.81709 1.49976 1.51193 0.81153 0.15175
    Cash From Investing Activities -0.00175 -0.06814 -0.06796 -0.05051 -0.03084
    Other Investing Cash Flow Items, Total 0 -0.0403 -0.04018 -0.04018 -0.03084
    Cash From Financing Activities 0.2315 5.17013 3.17834 2.60015 2.51221
    Financing Cash Flow Items -0.00407 -0.24043 -0.10356 -0.07444 -0.07444
    Issuance (Retirement) of Stock, Net 0.13557 2.8603 2.51871 2.48141 2.48141
    Issuance (Retirement) of Debt, Net 0.1 2.55026 0.76319 0.19319 0.10525
    Foreign Exchange Effects 0.00021 0.00344 0.00282 0.00264 0.00012
    Net Change in Cash -0.28125 0.08096 -0.19433 -0.04127 0.96596
    Capital Expenditures -0.00175 -0.02783 -0.02778 -0.01033
    Cash Interest Paid 0 0

    Hvorfor vælge Capital.com? Vores tal taler for sig selv.

    Capital.com Group

    535K+

    Handlende

    87K+

    Månedlkige, aktive klienter

    $113M+

    Månedlig investeringsvolumen

    $64M+

    Hævet hver måned

    Handelslommeregner

    Udregn dit hypotetiske P&L hvis du havde åbnet en CFD-handel på en given dato (vælg en dato) og lukket den på en anden dato (vælg en dato).

    Handelskurtage
    0
    • 1:1
    Gearing
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investering
    Handelsstørrelse (Gearing x Investering):
    Åben

    Luk

    Short Long
    Tidligere resultater er ikke en pålidelig indikator for fremtidige resultater
    Fortjeneste/Tab

    Avalon GloboCare Corp. Company profile

    Om Avalon GloboCare Corp.

    Avalon GloboCare Corp. er en vertikalt integreret CellTech bio-udviklingsvirksomhed i den kliniske fase. Virksomheden fokuserer på områderne cellulær immunterapi, herunder CAR-T/NK, exosom-teknologi (ACTEX) og COVID-19-relaterede vacciner og terapier gennem sine datterselskaber. Selskabet opererer gennem to forretningssegmenter: segmentet for ejendomsdrift og segmentet for medicinsk relaterede konsulenttjenester. Selskabet tilbyder også strategiske rådgivnings- og outsourcingtjenester for at lette og forbedre sine kunders vækst og udvikling samt forbedre deres konkurrenceevne på markederne inden for sundhedssektoren og CellTech-industrien. Selskabets nedstrøms medicinske team og facilitet består af tilknyttede hospitalsnetværk og eksperter specialiseret i hæmatologi, onkologi, cellulær immunterapi, transplantation af hæmatopoietiske stamceller/progenitorceller samt regenerative terapier. De kliniske programmer omfatter AVA-001, ACTEX, FLASH-CAR og AVA-Trap.

    Industry: Biotechnology & Medical Research (NEC)

    4400 Route 9
    Suite 3100
    07728

    Resultatopgørelse

    • Annual
    • Quarterly

    Folk ser også

    US100

    14,482.40 Price
    +1.300% 1D Chg, %
    Long position, gebyr natten over -0.0255%
    Short position, gebyr natten over 0.0032%
    Gebyr natten over, tid 21:00 (UTC)
    Spænd 1.8

    XRP/USD

    0.53 Price
    -0.020% 1D Chg, %
    Long position, gebyr natten over -0.0753%
    Short position, gebyr natten over 0.0069%
    Gebyr natten over, tid 21:00 (UTC)
    Spænd 0.00440

    Gold

    1,964.51 Price
    +1.250% 1D Chg, %
    Long position, gebyr natten over -0.0185%
    Short position, gebyr natten over 0.0103%
    Gebyr natten over, tid 21:00 (UTC)
    Spænd 0.30

    BTC/USD

    26,492.65 Price
    +0.260% 1D Chg, %
    Long position, gebyr natten over -0.0616%
    Short position, gebyr natten over 0.0137%
    Gebyr natten over, tid 21:00 (UTC)
    Spænd 60.00

    Leder du stadig efter en mægler, du kan stole på?

    Deltag sammen med 535.000+ handlende over hele verden, der valgte at handle hos Capital.com

    1. Opret og bekræft din konto 2. Lav en inddbetaling 3. Find din handel